Discover the latest insights on Novo Nordisk, a leading healthcare company. Learn why Cramer recommends stopping trading, and what investors need to know. Explore Novo Holdings' controlling shareholder role and CEO's thoughts on obesity sales boom & Catalent deal. Stay informed with our comprehensive overview.